Mail

Canada markets close in 5 hours 14 minutes

S&P/TSX
21,651.88
-62.66(-0.29%)
S&P 500
5,024.88
-10.81(-0.21%)
DOW
37,875.57
+59.65(+0.16%)
CAD/USD
0.7263
+0.0002(+0.02%)
CRUDE OIL
80.80
-1.13(-1.38%)
Bitcoin CAD
78,820.19
-5,375.08(-6.38%)

MARKETS LIVE BLOG

STOCKS TRADE MIXED WITH FED'S POWELL IN SPOTLIGHT

U.S. manufacturing sector sends a challenging signal for the Federal Reserve

Astria Therapeutics, Inc. (ATXS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

9.19

+0.01

(+0.11%)

As of 10:45AM EDT. Market open.

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	504.10M
Enterprise Value	353.22M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	N/A
Price/Book (mrq)	3.41
Enterprise Value/Revenue	N/A
Enterprise Value/EBITDA	-5.21

Trading Information

Stock Price History

Beta (5Y Monthly)	0.71
52-Week Change ³	-27.89%
S&P500 52-Week Change ³	23.10%
52 Week High ³	16.90
52 Week Low ³	4.26
50-Day Moving Average ³	12.81
200-Day Moving Average ³	9.00

Share Statistics

Avg Vol (3 month) ³	1.01M
Avg Vol (10 day) ³	868.21k
Shares Outstanding ⁵	54.91M
Implied Shares Outstanding ⁶	54.91M
Float ⁸	36.14M
% Held by Insiders ¹	0.49%
% Held by Institutions ¹	86.09%
Shares Short (Apr 15, 2024) ⁴	5.05M
Short Ratio (Apr 15, 2024) ⁴	3.32
Short % of Float (Apr 15, 2024) ⁴	9.55%
Short % of Shares Outstanding (Apr 15, 2024) ⁴	9.19%
Shares Short (prior month Mar 15, 2024) ⁴	2.01M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	Dec 31, 2018
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:6
Last Split Date ³	Aug 20, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Dec 31, 2023

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	-17.47%
Return on Equity (ttm)	-31.40%

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	N/A
Net Income Avi to Common (ttm)	-72.89M
Diluted EPS (ttm)	-2.42
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	246.53M
Total Cash Per Share (mrq)	4.49
Total Debt (mrq)	329k
Total Debt/Equity (mrq)	0.14%
Current Ratio (mrq)	21.73
Book Value Per Share (mrq)	3.60

Cash Flow Statement

Operating Cash Flow (ttm)	-68.44M
Levered Free Cash Flow (ttm)	-36.52M